Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice - Results from a cluster-randomized controlled trial of implementation of a clinical practice guideline

Journal of Evaluation in Clinical Practice

Volumn 14, Issue 5, 2008, Pages 823-829

  Peters Klimm, Frank ^a   Müller Tasch, Thomas ^b   Remppis, Andrew ^a   Szecsenyi, Joachim ^a   Schellberg, Dieter ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

Continuing medical education; Drug therapy; Family practice; Guideline adherence; Heart failure; Primary health care; Professional practice

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC HEART FAILURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLUSTER ANALYSIS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; GERMANY; GUIDELINE ADHERENCE; HEART FAILURE, SYSTOLIC; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; QUALITY OF HEALTH CARE;

EID: 55349085471     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2008.01060.x     Document Type: Article

References (31)

1. McMurray, J. J. Pfeffer, M. A. (2005) Heart failure. Lancet, 365 (9474 1877 1889.
2. O'Connell, J. B. (2000) The economic burden of heart failure. Clinical Cardiology, 23 (3 Suppl 6 10.
3. Shekelle, P. G., Rich, M. W., Morton, S. C., Atkinson, C. S., Tu, W., Maglione, M., et al 2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. Journal of the American College of Cardiology, 41 (9 1529 1538.
4. Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J. Wittes, J. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. The New England Journal of Medicine, 341 (10 709 717.
5. Hoppe, U. C., Bohm, M., Dietz, R., Hanrath, P., Kroemer, H. K., Osterspey, A., Schmaltze, A. A. Erdmann, E. (2005 Guidelines for therapy of chronic heart failure Zeitschrift fur Kardiologie, 94 (8 488 509.
6. Swedberg, K., Cleland, J., Dargie, H., et al 2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. European Heart Journal, 26 (11 1115 1140.
7. Cleland, J. G., Cohen-Solal, A., Aguilar, J. C., et al 2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet, 360 (9346 1631 1639.
8. Lenzen, M. J., Boersma, E., Scholte op Reimer, W. J. M., Balk, A. H. M. M., Komajda, M., Swedberg, K., Follath, F., Jimenez-Navarro, M., Simoons, M. L. Cleland, J. G. F. (2005) Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. European Heart Journal, 26 (24 2706 2713.
9. Komajda, M., Lapuerta, P., Hermans, N., Gonzalez-Juanatey, J. R., van Veldhuisen, D. J., Erdmann, E., Tavazzi, L., Poole-Wilson, P. Le Pen, C. (2005) Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. European Heart Journal, 26 (16 1653 1659.
10. Mehta, R. H., Peterson, E. D. Califf, R. M. (2007) Performance measures have a major effect on cardiovascular outcomes: a review. The American Journal of Medicine, 120 (5 398 402.
11. Julian, D. G. (2004) Translation of clinical trials into clinical practice. Journal of Internal Medicine, 255 (3 309 316.
12. Freeman, A. C. Sweeney, K. (2001) Why general practitioners do not implement evidence: qualitative study. BMJ, 323 (7321 1100 1102.
13. Lainscak, M., Cleland, J. G., Lenzen, M. J., Follath, F., Komajda, M. Swedberg, K. (2007) International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. European Journal of Heart Failure, 9 (3 292 299.
14. de Groote, P., Isnard, R., Assyag, P., Clerson, P., Ducardonnet, A., Galinier, M., Jondeau, G., Leurs, I., Thebaut, J. F. Komajda, M. (2007) Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. European Journal of Heart Failure, 9 (12 1205 1211.
15. Grimshaw, J. M., Thomas, R. E., MacLennan, G., et al 2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment, 8 (6 iii 72.
16. Grol, R. Grimshaw, J. (2003) From best evidence to best practice: effective implementation of change in patients' care. Lancet, 362 (9391 1225 1230.
17. Bloom, B. S. (2005) Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. International Journal of Technology Assessment in Health Care, 21 (3 380 385.
18. Peters-Klimm, F., Muller-Tasch, T., Schellberg, D., Remppis, A., Barth, A., Holzapfel, N., Junger, J., Herzog, W. Szecsenyi, J. (2007) Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clinical Research in Cardiology, 97 (4 244 252.
19. Luke, D. R., Halstenson, C. E., Opsahl, J. A. Matzke, G. R. (1990) Validity of creatinine clearance estimates in the assessment of renal function. Clinical Pharmacology and Therapeutics, 48 (5 503 508.
20. Harden, R. M., Grant, J., Buckley, G. Hart, I. R. (2000) Best evidence medical education. Advances in Health Sciences Education: Theory and Practice, 5 (1 71 90.
21. Thomson O'Brien, M. A., Oxman, A. D., Davis, D. A., Haynes, R. B., Freemantle, N. Harvey, E. L. (2000) Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews, Issue 2, CD000259.
22. Thomson O'Brien, M. A., Freemantle, N., Oxman, A. D., Wolf, F., Davis, D. A. Herrin, J. (2001) Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews, Issue 2, CD003030.
23. Rutten, F. H., Grobbee, D. E. Hoes, A. W. (2003) Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. European Journal of Heart Failure, 5 (3 337 344.
24. Bongers, F. J., Schellevis, F. G., Bakx, C., van den Bosch, W. J. van der Zee J. (2006) Treatment of heart failure in Dutch general practice. BMC Family Practice, 7, 40.
25. Kasje, W. N., Denig, P., Stewart, R. E., de Graeff, P. A. Haaijer-Ruskamp, F. M. (2006) An educational programme for peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in general practice. Journal of Evaluation in Clinical Practice, 12 (6 613 621.
26. Thilly, N., Briancon, S., Juilliere, Y., Dufay, E. Zannad, F. (2003) Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use. Journal of Evaluation in Clinical Practice, 9 (3 373 382.
27. Fugh-Berman, A. Ahari, S. (2007) Following the script: how drug reps make friends and influence doctors. PLoS Medicine, 4 (4 e150.
28. Ansari, M., Shlipak, M. G., Heidenreich, P. A., Van Ostaeyen, D., Pohl, E. C., Browner, W. S. Massie, B. M. (2003) Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation, 107 (22 2799 2804.
29. LaPointe, N. M., DeLong, E. R., Chen, A., Hammill, B. G., Muhlbaier, L. H., Califf, R. M. Kramer, J. M. (2006) Multifaceted intervention to promote beta-blocker use in heart failure. American Heart Journal, 151 (5 992 998.
30. Mehta, P. A., McDonagh, S., Poole-Wilson, P. A., Grocott-Mason, R. Dubrey, S. W. (2004) Heart failure in a district general hospital: are target doses of beta-blockers realistic? QJM, 97 (3 133 139.
31. Gupta, R., Tang, W. H. Young, J. (2004) Patterns of beta-blocker utilization in patients with chronic heart failure: experience from a specialized outpatient heart failure clinic. American Heart Journal, 147 (1 79 83.